Tag Archives: buyout

We’ve been highlighting Pernix Therapeutics Holdings Inc (NASDAQ:PTX) as a potential buyout candidate for some time now. Since Sedor took over as interim Chief in May last year, and was subsequently appointed as permanent to the role a few...

xG Technology Inc (NASDAQ:XGTI) ran up a few percentage points last week, and the company currently trades for just shy of $1.50 a piece. That’s a circa 10% premium to the 2017 open, but it’s down more than 40% on January highs,...

The manufacturing company, Cleantech Solutions International, Inc. (NASDAQ: CLNT), is our new profile. On April 7, 2017, the company received a letter from the Nasdaq informing CLNT that it regained compliance with Nasdaq listing requitement....

Bioline Rx Ltd. (NASDAQ: BLRX), a clinical stage biopharmaceutical development company working on oncology and immunology products, looks like an opportunity right now. On March 31, 2017, the company announced an underwritten public offering...

Innocoll Holdings PLC (NASDAQ:INNL) is a big winner early this week on the news that the company is set to be bought out by a healthcare investment fund. We don’t like to blow our own trumpet here at Insider Financial, but with this one,...

xG Technology Inc (NASDAQ:XGTI) is a company we’ve come back to on a few occasions over the last twelve months here at Insider Financial. In our most recent coverage, we noted that the company was running up on the back of seemingly no...

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has taken a hit this week on the back of management putting out the company’s latest financials and holding a conference call to accompany the release. The numbers, which detail full year...

At the beginning of February, we took a look at development stage biotech company Pulmatrix Inc (NASDAQ:PULM) as part of this piece.  At the time, the company had just run up to the tune of 130% on the back of an expedited approval process...

xG Technology Inc (NASDAQ:XGTI) has had a pretty tough start to 2017, with the company down 44% as of Thursday’s close from its January 10 highs. However, as the markets opened on Friday morning in the US, xG picked up some volume, and...

Full-year 2016 financials are hitting press thick and fast in the biotech space right now, and injecting plenty of volatility into the sector. One company that just put out its numbers, but is really moving for a variety of other reasons, is...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter